4//SEC Filing
Cranston Lynda Sarah 4
Accession 0001213900-19-007624
CIK 0001498382other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 6:29 PM ET
Size
5.5 KB
Accession
0001213900-19-007624
Insider Transaction Report
Form 4
Cranston Lynda Sarah
Director
Transactions
- Disposition to Issuer
Performance Stock Units
2019-04-30−200,000→ 0 totalExp: 2022-07-07→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]Each performance stock unit represents the right to receive one share of common stock, to vest upon achievement of specified targets related to the Company's financial performance. Such performance stock units were unvested.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001633660
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 6:29 PM ET
- Size
- 5.5 KB